维普中文期刊产品整合服务
249篇 您的检索式:作者名="D. Anderson"
    题名 作者 年代 出处 被引量
1罗东(台湾)土—结构相互作用大比例模型试验的启示(Ⅰ)显示文摘地震反应预测结果评估——逐个方法评估评估地震反应结果的基本方法,是将结构预先选定点上的阻尼比为5%的加速度反应谱与其记录反应谱进行对比。虽然报告提到了好几个点的反应。A. H. Hadjian W. S. Tseng C. Y. Chang D. Anderson N. C. Tsai Y. K. Tang H. T. Tang J. C. Stepp 谢君斐 1993世界地震工程1993,9,3:9
2Geographical distribution of red and green Noctiluca scintillans显示文摘The dinoflagellate Noctiluca scintillans is one of the most important and abundant red tide organisms and it is distributed world-wide. It occurs in two forms. Red Noctiluca is heterotrophic and fills the role of one of the microzooplankton grazers in the foodweb. In contrast, green Noctiluca contains a photosynthetic symbiont Pedinomonas noctilucae (a prasinophyte), but it also feeds on other plankton when the food supply is abundant. In this review, we document the global distribution of these two forms and include the first maps of their global distribution. Red Noctiluca occurs widely in the temperate to sub-tropical coastal regions of the world. It occurs over a wide temperature range of about 10°C to 25°C and at higher salinities (generally not in estuaries). It is particularly abundant in high productivity areas such as upwelling or eutrophic areas where diatoms dominate since they are its preferred food source. Green Noctiluca is much more restricted to a temperature range of 25°C-30°C and mainly occurs in tropical waters of Southeast Asia, Bay of Bengal (east coast of India), in the eastern, western and northern Arabian Sea, the Red Sea, and recently it has become very abundant in the Gulf of Oman. Red and green Noctiluca do overlap in their distribution in the eastern, northern and western Arabian Sea with a seasonal shift from green Noctiluca in the cooler winter convective mixing, higher productivity season, to red Noctiluca in the more oligotrophic warmer summer season.P. J. HARRISON K. FURUYA P. M. GLIBERT J. Xu H. B. LIU K. YIN J. H. W. LEE D. M. ANDERSON R. GOWEN A. R. AL-AZRI A. Y. T. HO 2011Chinese Journal of Oceanology and Limnology2011,29,4:8
31999~2006年急性冠脉综合征患者死亡及心力衰竭发生率降低显示文摘背景:有关药物和介入治疗对ST段抬高型和非ST段抬高型急性冠脉综合征(non—ST-segment elevation acute coronary syndrome,NSTE ACS)患者的作用,随机试验已经提供了足够的证据,但是是否已经转化为相应的临床变化还不清楚。 目的:确定ST段抬高型心肌梗死(ST-segment elevation myocardial infarction,STEMI)和NSTE ACS患者的院内治疗改变是否伴随临床结果的改善。 设计、地点及患者:全球急性冠脉事件注册研究(Global Registry of Acute Coronary Events,GRACE)是一项多国家队列研究。自1999年7月1日至2006年12月31日,该研究共入选并随访了来自14个国家、113家医院的44372例ACS患者。 主要观测指标:当前循证药物和介入治疗应用的趋势及患者预后(死亡、充血性心力衰竭、肺水肿、心源性休克、卒中和心肌梗死)。 结果:随着研究时间的进展,相关药物的应用增加(β-受体阻滞剂、他汀类药物、血管紧张素转换酶抑制剂、行或未行经皮冠状动脉介入治疗[percutaneous coronary intervention,PCI]患者应用噻氯毗啶、糖蛋白Ⅱb/Ⅲa抑制剂和低分子肝素;P〈0.001)。STEMI患者药物再灌注治疗下降了22个百分点(95%可信区间[confidence interval,CI],-27~-17),而直接PCI增加了37个百分点(95%CI,33—41)。在NSTEMI患者中,PCI的比例显著升高了18个百分点(95%CI,15~20)。充血性心力衰竭和肺水肿在STEMI患者中降低了9个百分点(95%CI,-12~-6),在NSTEACS患者中降低了6.9个百分点(95%CI,-8.4~-4.7)。STEMI患者的院内死亡率降低了18个百分点(95%CI,-5.3~-1.9),心源性休克降低了24个百分点(95%CI,-4.3~-0.5)。校正了危险评分后,NSTEACS患者的院内死亡率降低了0.7个百分点(95%CI,-1.7~0.3);STEMI患者6个月随访时卒中发生率降低了0.8个百分点(95%CI,-1.7~0.1),心肌梗死发生率降低了2.8个百分点(95%CI,-6.4~0.9)。NSTEACS患者6个月死亡率降低了1.6个百分点(95%CI,-3.0~-0.1),卒中发生率降低了0.7个百分点(95%CI,-1.4~0.1)。 结论:在本项多国家观察性研究中,ACS患者治疗的改善与6个月新发心力衰竭、死亡率、卒中和心肌梗死发生率显著降低相关。Keith A. A. Fox Philippe Gabriel Steg Kim A. Eagle Shaun G. Goodman Frederick A. Anderson Christopher B. Granger Marcus D. Flather Andrzej Budaj Ann Quill Joel M. Gore 康俊萍(译) 马长生(校) 2007美国医学会杂志(中文版)2007,26,6:6
4Characterization of the Intestinal Cancer Stem Cell Marker CD166 in the Human and Mouse Gastrointestinal Tract显示文摘Trevor G. Levin Anne E. Powell Paige S. Davies Alain D. Silk Adria D. Dismuke Eric C. Anderson John R. Swain Melissa H. Wong 2010Gastroenterology2010,,:2
52012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction显示文摘Jeffrey L. Anderson Cynthia D. Adams Elliott M. Antman Charles R. Bridges Robert M. Califf Donald E. Casey William E. Chavey Francis M. Fesmire Judith S. Hochman Thomas N. Levin A. Michael Lincoff Eric D. Peterson Pierre Theroux Nanette K. Wenger R. Scott 2013Journal of the American College of Cardiology2013,,23:2
6Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation显示文摘William C. Chapman M B. Majella Doyle Jourdan E. Stuart Neeta Vachharajani Jeffrey S. Crippin Christopher D. Anderson Jeffrey A. Lowell Surendra Shenoy Michael D. Darcy Daniel B. Brown 2008Annals of Surgery2008,,4:2
7Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial显示文摘E. Zolotarevsky S. Fehmi M. Anderson P. Schoenfeld B. Elmunzer R. Kwon C. Piraka E.-J. Wamsteker J. Scheiman S. Korsnes D. Normolle H. Kim G. Elta 2011Endoscopy2011,,04:2
8Advanced Donor Age Alone Does Not Affect Patient or Graft Survival after Liver Transplantation显示文摘Christopher D. Anderson Neeta Vachharajani Majella Doyle Jeffrey A. Lowell Jason R. Wellen Surendra Shenoy Mauricio Lisker-Melman Kevin Korenblat Jeff Crippin William C. Chapman 2008Journal of the American College of Surgeons2008,,6:2
9The role of endoscopy in the management of obscure GI bleeding显示文摘Laurel Fisher Mary Lee Krinsky Michelle A. Anderson Vasundhara Appalaneni Subhas Banerjee Tamir Ben-Menachem Brooks D. Cash G. Anton Decker Robert D. Fanelli Cindy Friis Norio Fukami M. Edwyn Harrison Steven O. Ikenberry Rajeev Jain Terry Jue Khalid Khan 2010Gastrointestinal Endoscopy2010,,3:2
10Combined effects of type 2 diabetes and hypertension associated with cortical thinning and impaired cerebrovascular reactivity relative to hypertension alone in older adults显示文摘Ekaterina Tchistiakova Nicole D. Anderson Carol E. Greenwood Bradley J. MacIntosh 2014NeuroImage: Clinical2014,,:2
11国际卒中遗传学联盟的推荐意见(第2部分):生物样本的采集和储存显示文摘在2003年人类基因组测序以及全基因组基因分型技术发展的共同促进下,人类遗传学的进步已使我们识别出2000多个与性状相关的基因突变。由于这些突变大多数对疾病风险仅有微小的独立影响,因此成功的遗传学研究需要很大的样本量(包含数以千计、万计或者十万计的病例和对照)才能达到足够的研究效能。如此大的样本量积累需要依赖在人类遗传学研究乃至在临床研究中史无前例的大规模国际协作。现在已有许多常见疾病的专病联盟将大量独立机构和合作者联合起来。每个联盟均面临至少2个基本问题:如何整合具有足够数量、同质性和表型质量高的研究样本以及如何储存和分析来自入组受试者的生物样本,有时可能需要在数年间反复进行。Thomas W.K.Battey Valerie Valant Sylvia Baedorf Kassis Christina Kourkoulis Chaeyoung Lee Christopher D. Anderson Guido J. Falcone Jordi Jimenez-Conde Israel Fernandez-Cadenas Guillaume Pare Tatjana Rundek Michael L. James Robin Lemmens Tsong-Hai Lee Turgut Tatlisumak Steven J. Kittner Arne Lindgren Farrah J. Mateen Aaron L. Berkowitz Elizabeth G. Holliday Jennifer Majersik 李海峰 姜平 岳耀先 2015国际脑血管病杂志2015,23,9:2
12Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure显示文摘Maria Rosa Costanzo Maya E. Guglin Mitchell T. Saltzberg Mariell L. Jessup Bradley A. Bart John R. Teerlink Brian E. Jaski James C. Fang Erika D. Feller Garrie J. Haas Allen S. Anderson Michael P. Schollmeyer Paul A. Sobotka 2007Journal of the American College of Cardiology2007,,6:2
13The role of endoscopy in the evaluation of suspected choledocholithiasis显示文摘John T. Maple Tamir Ben-Menachem Michelle A. Anderson Vasundhara Appalaneni Subhas Banerjee Brooks D. Cash Laurel Fisher M. Edwyn Harrison Robert D. Fanelli Norio Fukami Steven O. Ikenberry Rajeev Jain Khalid Khan Mary Lee Krinsky Laura Strohmeyer Jason A 2010Gastrointestinal Endoscopy2010,,1:2
14Complications of ERCP显示文摘Michelle A. Anderson Laurel Fisher Rajeev Jain John A. Evans Vasundhara Appalaneni Tamir Ben-Menachem Brooks D. Cash G. Anton Decker Dayna S. Early Robert D. Fanelli Deborah A. Fisher Norio Fukami Joo Ha Hwang Steven O. Ikenberry Terry L. Jue Khalid M. Kh 2012Gastrointestinal Endoscopy2012,,3:2
15Management of antithrombotic agents for endoscopic procedures显示文摘Michelle A. Anderson Tamir Ben-Menachem S. Ian Gan Vasundhara Appalaneni Subhas Banerjee Brooks D. Cash Laurel Fisher M. Edwyn Harrison Robert D. Fanelli Norio Fukami Steven O. Ikenberry Rajeev Jain Khalid Khan Mary Lee Krinsky David R. Lichtenstein John 2009Gastrointestinal Endoscopy2009,,6:2
16Psychometric considerations in evaluating health-related quality of life measures显示文摘R. D. Hays R. Anderson D. Revicki 1993Quality of Life Research1993,,6:2
172012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)显示文摘Hani Jneid Jeffrey L. Anderson R. Scott Wright Cynthia D. Adams Charles R. Bridges Donald E. Casey Steven M. Ettinger Francis M. Fesmire Theodore G. Ganiats A. Michael Lincoff Eric D. Peterson George J. Philippides Pierre Theroux Nanette K. Wenger James P 2012Journal of the American College of Cardiology2012,,7:1
18Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors?显示文摘Jeffrey L. Anderson Ryan C. Vanwoerkom Benjamin D. Horne Tami L. Bair Heidi T. May Donald L. Lappé Joseph B. Muhlestein 2011American Heart Journal2011,,2:1
19Close relation of endothelial function in the human coronary and peripheral circulations显示文摘Todd J. Anderson Akimi Uehata Marie D. Gerhard Ian T. Meredith Sarah Knab Danielle Delagrange Eric H. Lieberman Peter Ganz Mark A. Creager Alan C. Yeung Andrew P. Selwyn 1995Journal of the American College of Cardiology1995,,5:1
20Acute Heart Failure Syndromes: Emergency Department Presentation, Treatment, and Disposition: Current Approaches and Future Aims: A Scientific Statement From the American Heart Association显示文摘Neal L. Weintraub Sean P. Collins Peter S. Pang Phillip D. Levy Allen S. Anderson Cynthia Arslanian-Engoren W. Brian Gibler James K. McCord Mark B. Parshall Gary S. Francis Mihai Gheorghiade 2010Circulation2010,,:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费